An FDA advisory body recommends booster vaccinations of this vaccine

While booster vaccinations are mostly approved for people over 65 years of age (including those who are immunocompromised or at higher risk due to their work), a panel of the Food and Drug Administration (FDA) recently approved a booster vaccination for Johnson. approves & Johnson vaccine.

According to NBC News, the FDA panel’s vote was unanimous and the FDA is now expected to receive the decision soon. You will then decide in the coming days whether the booster will be approved or not. If approved, the Johnson & Johnson booster would be available to the 15 million people over the age of 18 who received the vaccination sometime in the past year.

RELATED: These people should be the last in line for COVID-19 boosters, experts say

Photo by Towfiqu barbhuiya via Unsplash

The Panel believes that this vote is justified because the Johnson & Johnson vaccine is less effective. Studies have shown that refreshing these vaccines could increase their protection rate by up to 94%. However, the Johnson & Johnson vaccine was not designed as a two-dose vaccine. It works differently than Moderna and Pfizer’s two-dose immunization.

Despite evidence to the contrary, Johnson & Johnson executives claim that a single dose remains effective, which has been criticized by the FDA. “I honestly think this was always a two-dose vaccine,” said Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

RELATED: Doing this after your first dose of COVID-19 may result in decreased protection against viruses

The Johnson & Johnson vaccine was 72% effective against moderate to severe illness, well below the 95% protection rate provided by Moderna or Pfizer. According to the Centers for Disease Control and Prevention (CDC), most of the groundbreaking COVID-19 cases have come from people vaccinated with the Johnson & Johnson vaccine.

If the FDA approved this decision, people over the age of 18 could receive their Johnson & Johnson boosters within two months of their first injection.